350 related articles for article (PubMed ID: 37654493)
1. Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease.
Jiang Z; Jiang X; Chen A; He W
Front Immunol; 2023; 14():1238647. PubMed ID: 37654493
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.
Visser MJE; Tarr G; Pretorius E
Front Immunol; 2021; 12():688861. PubMed ID: 34335591
[TBL] [Abstract][Full Text] [Related]
3. Platelets: Underestimated Regulators of Autoinflammation in Psoriasis.
Herster F; Karbach S; Chatterjee M; Weber ANR
J Invest Dermatol; 2021 Jun; 141(6):1395-1403. PubMed ID: 33810836
[TBL] [Abstract][Full Text] [Related]
4. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
Guttman-Yassky E; Krueger JG; Lebwohl MG
Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
[TBL] [Abstract][Full Text] [Related]
5. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
Papp K; Poulin Y; Vieira A
J Cutan Med Surg; 2013; 17(2):89-105. PubMed ID: 23582163
[TBL] [Abstract][Full Text] [Related]
6. Platelet Dysfunction and Its Role in the Pathogenesis of Psoriasis.
Fan Z; Wang L; Jiang H; Lin Y; Wang Z
Dermatology; 2021; 237(1):56-65. PubMed ID: 32349003
[TBL] [Abstract][Full Text] [Related]
7. [Comorbidity in psoriasis].
Gerdes S; Mrowietz U; Boehncke WH
Hautarzt; 2016 Jun; 67(6):438-44. PubMed ID: 27221798
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis and cardiovascular disease.
Vena GA; Vestita M; Cassano N
Dermatol Ther; 2010; 23(2):144-51. PubMed ID: 20415821
[TBL] [Abstract][Full Text] [Related]
9. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.
Boehncke WH
Front Immunol; 2018; 9():579. PubMed ID: 29675020
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
Puig L
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.
Garshick MS; Ward NL; Krueger JG; Berger JS
J Am Coll Cardiol; 2021 Apr; 77(13):1670-1680. PubMed ID: 33795041
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics.
Weber B; Merola JF; Husni ME; Di Carli M; Berger JS; Garshick MS
Curr Atheroscler Rep; 2021 Sep; 23(11):67. PubMed ID: 34468875
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
Davidovici BB; Sattar N; Prinz J; Puig L; Emery P; Barker JN; van de Kerkhof P; Ståhle M; Nestle FO; Girolomoni G; Krueger JG
J Invest Dermatol; 2010 Jul; 130(7):1785-96. PubMed ID: 20445552
[TBL] [Abstract][Full Text] [Related]
14. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.
Marin Oyarzún CP; Heller PG
Front Immunol; 2019; 10():1373. PubMed ID: 31258539
[TBL] [Abstract][Full Text] [Related]
15. GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
Joshi AA; Lerman JB; Aberra TM; Afshar M; Teague HL; Rodante JA; Krishnamoorthy P; Ng Q; Aridi TZ; Salahuddin T; Natarajan B; Lockshin BN; Ahlman MA; Chen MY; Rader DJ; Reilly MP; Remaley AT; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
Circ Res; 2016 Nov; 119(11):1242-1253. PubMed ID: 27654120
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, atherosclerosis, and psoriasis.
Siegel D; Devaraj S; Mitra A; Raychaudhuri SP; Raychaudhuri SK; Jialal I
Clin Rev Allergy Immunol; 2013 Apr; 44(2):194-204. PubMed ID: 22359071
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis and its comorbidities.
Onumah N; Kircik LH
J Drugs Dermatol; 2012 May; 11(5 Suppl):s5-10. PubMed ID: 22644770
[TBL] [Abstract][Full Text] [Related]
19. The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice.
Salamah MF; Vallance TM; Kodji X; Ravishankar D; Williams HF; Brain SD; Vaiyapuri S
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887440
[TBL] [Abstract][Full Text] [Related]
20. Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis.
Egeberg A; Bruun LE; Mallbris L; Gislason GH; Skov L; Wu JJ; Hansen PR
J Am Acad Dermatol; 2016 Aug; 75(2):340-6. PubMed ID: 27283226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
